Infants of Human Immunodeficiency Virus Type 1-Infected Women in Rural South India

被引:4
|
作者
Read, Jennifer S. [1 ]
Samuel, N. M. [2 ]
Srijayanth, Parameshwari [2 ]
Dharmarajan, Shoba [2 ]
Van Hook, Hannah M. [3 ]
Jacob, Mini [2 ]
Junankar, Viju [3 ]
Bethel, James [3 ]
Yu, Eunice [3 ]
Stoszek, Sonia K.
机构
[1] NICHD, Pediat Adolescent & Maternal AIDS Branch, NIH, Bethesda, MD USA
[2] Tamil Nadu Dr MGR Med Univ, Dept Expt Med, Madras, Tamil Nadu, India
[3] WESTAT Corp, Rockville, MD 20850 USA
基金
美国国家卫生研究院;
关键词
infant feeding; HIV-1; mother-to-child transmission; India; TO-CHILD TRANSMISSION; BREAST-MILK; HIV-1;
D O I
10.1097/INF.0b013e3181b20ffc
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: We assessed the infant feeding choices of HIV-1-infected women in rural Tamil Nadu, India, and risk factors for mother-to-child transmission of HIV-1. Methods: The study population comprised live born infants of HIV-1-infected women from the antenatal clinics of 2 public hospitals in rural Tamil Nadu, India who were enrolled in a prospective cohort study. All women enrolled in the cohort were offered antiretroviral prophylaxis and infant feeding counseling based on WHO/UNAIDS/UNICEF training materials. Infant study visits were scheduled at birth (within the first 24 hours of life), at 1 week, 1 month, and 2 months after birth, and then every 2 months between 4 and 12 months of age. Results: One-third of women did not breast-feed their infants. Of those who initiated breast-feeding, the median duration of breast-feeding was approximately 3 months. Among those infants who initiated breast-feeding, the proportion exclusively breast-feeding declined from approximately 70% during the first week of life to 0% by the 8 month visit. The observed rate of mother-to-child transmission of HIV-1 in the entire cohort was 6.5% (95% CI: 1.4%-17.9%). The observed HIV-1 incidence among breast-fed infants was 0% (95% CI: 0%-8.9%). Conclusion: The overall transmission rate was relatively low, suggesting effectiveness of antiretroviral transmission prophylaxis. the infant feeding choices made may reflect knowledge gained through the educational program and infant feeding counseling provided. Ensuring HIV-1-infected women receive appropriate HIV-1 treatment (for those who meet criteria for treatment) and access to known efficacious interventions to prevent mother-to-child transmission of HIV-1, are essential.
引用
收藏
页码:14 / 17
页数:4
相关论文
共 50 条
  • [1] Cervical shedding of cytomegalovirus in human immunodeficiency virus type 1-infected women
    Mostad, SB
    Kreiss, JK
    Ryncarz, AJ
    Overbaugh, J
    Mandaliya, K
    Chohan, B
    Ndinya-Achola, J
    Bwayo, JJ
    Corey, L
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1999, 59 (04) : 469 - 473
  • [2] Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants
    Rodman, JH
    Flynn, PM
    Robbins, B
    Jimenez, E
    Bardeguez, AD
    Rodriguez, JF
    Blanchard, S
    Fridland, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06): : 1844 - 1850
  • [3] Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India
    Mehendale, SM
    Bollinger, RC
    Kulkarni, SS
    Stallings, RY
    Brookmeyer, RS
    Kulkarni, SV
    Divekar, AD
    Gangakhedkar, RR
    Joshi, SN
    Risbud, AR
    Thakar, MA
    Mahajan, BA
    Kale, VA
    Ghate, MV
    Gadkari, DA
    Quinn, TC
    Paranjape, RS
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (16) : 1175 - 1179
  • [4] Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates
    Mirochnick, M
    Fenton, T
    Gagnier, P
    Pav, J
    Gwynne, M
    Siminski, S
    Sperling, RS
    Beckerman, K
    Jimenez, E
    Yogev, R
    Spector, SA
    Sullivan, JL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02): : 368 - 374
  • [5] Pregnancy and human herpesvirus 8 reactivation in human immunodeficiency virus type 1-infected women
    Lisco, Andrea
    Barbierato, Massimo
    Fiore, Jose R.
    Gasperini, Paola
    Favia, Anna
    Volpe, Anna
    Chironna, Maria
    Pastore, Giuseppe
    Chieco-Bianchi, Luigi
    Calabro, Maria Luisa
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (11) : 3863 - 3871
  • [6] Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants
    Faye, A
    Bertone, C
    Teglas, JP
    Chaix, ML
    Douard, D
    Firtion, G
    Thuret, I
    Dollfus, C
    Monpoux, F
    Floch, C
    Nicolas, J
    Vilmer, E
    Rouzioux, C
    Mayaux, MJ
    Blanche, S
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (06) : 518 - 525
  • [7] Temporary seronegativity in a human immunodeficiency virus type 1-infected man
    Zaaijer, HL
    Bloemer, MH
    Lelie, PN
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1997, 51 (01) : 80 - 82
  • [8] Population Pharmacokinetics of Emtricitabine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their Neonates
    Hirt, Deborah
    Urien, Saik
    Rey, Elisabeth
    Arrive, Elise
    Ekouevi, Didier K.
    Coffie, Patrick
    Leang, Sim Kruy
    Lalsab, Sarita
    Avit, Divine
    Nerrienet, Eric
    McIntyre, James
    Blanche, Stephane
    Dabis, Francois
    Treluyer, Jean-Marc
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) : 1067 - 1073
  • [9] Cytomegalovirus infection in human immunodeficiency virus type 1-infected children
    Chandwani, S
    Kaul, A
    Bebenroth, D
    Kim, M
    DiJohn, D
    Fidelia, A
    Hassel, A
    Borkowsky, W
    Krasinski, K
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (04) : 310 - 314
  • [10] Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants
    Rich, KC
    Fowler, MG
    Mofenson, LM
    Abboud, R
    Pitt, J
    Diaz, C
    Hanson, IC
    Cooper, E
    Mendez, H
    [J]. PEDIATRICS, 2000, 105 (01) : e8